CardioCommand

What CardioCommand does

CardioCommand, Inc., headquartered in Tampa, Florida, is a privately held medical device company that designs, develops, and manufactures FDA-cleared systems for transesophageal atrial pacing (TAP). Founded in 1994, the company's platform exploits the anatomical proximity between the esophagus and the left atrium to enable minimally invasive temporary cardiac pacing, electrical activity monitoring, and cardioversion of arrhythmias without surgical incision or intravascular catheterization. Its portfolio is organized around two named platforms: TAPSTRESS, used for non-exercise cardiac stress testing and electrophysiology (EP) studies, and TAPSYSTEM, deployed in anesthesiology and surgery for intraoperative and postoperative heart-rate control. Core reusable capital equipment consists of the Model 7A Stimulator, Model 3 Preamplifier, and TAPSYSTEM Model 2A pulse generator, each engineered to interface with the company's family of disposable esophageal bipolar and octapolar pacing/recording catheters (TAPCATH and TAPSCOPE series) that span 5F-18F sizing and include thermistor-equipped variants for ablation temperature monitoring.

CardioCommand runs a direct, sales-led go-to-market model aimed at hospital cardiology, electrophysiology, and anesthesiology departments, with orders and technical support routed through its Tampa headquarters. Revenue is generated through three streams: capital equipment sales, recurring disposable catheter sales (TAPCATH 205, TAPCATH Model 1600, TAPSCOPE 210, TAPSCOPE 550), and accessories/cables. Pricing is not publicly disclosed. The company's commercial footprint is documented through more than 35 named US academic medical centers and health systems — including Mayo Clinic, Johns Hopkins Medicine, Boston Children's Hospital, Cleveland Clinic, UCSF Health, Stanford School of Medicine, Duke University Medical Center, MD Anderson Cancer Center, UPMC, Memorial Hermann, Yale New Haven Health, and Walter Reed Army Medical Center — establishing a presence across adult cardiology, pediatric cardiology, and anesthesia service lines. Marketing is conducted primarily through clinical evidence (250+ peer-reviewed studies and abstracts) and a content-led company website that supports direct inbound sales inquiries.

The technology is protected by a registered patent on TAP Technology and benefits from established FDA clearances and CPT reimbursement codes, which together create a regulatory and IP-based barrier to entry. CardioCommand's competitive position is differentiated by clinical evidence depth rather than scale: the firm is described as the only US company whose products are designed exclusively for monitoring temperature and cardiac activity within the esophagus. The company is small — 11-50 employees — with a lean leadership team (President & CEO Chip Ross, VP of Corporate Services Cathy Conley, Marketing Manager Stephanie Ortega), no disclosed institutional investors, and operations confined to the US market. There is no evidence in the input data of recent funding, M&A, partnership, or major product-launch activity that would indicate an inflection point.

Name

CardioCommand

Legal name

CardioCommand, Inc.

Website

https://cardiocommand.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

CardioCommand is a Tampa, Florida-based medical device company designing, manufacturing, and selling FDA-cleared transesophageal atrial pacing systems and disposable esophageal catheters to hospital cardiology, electrophysiology, and anesthesiology departments across the United States.

Ownership category

akta.pro rank

Product category

Cardiac Pacing and Monitoring Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro industry

PRIMARYHLAHAFAC

Cardiac Rhythm Management (Pacemakers, ICDs, CRT)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

SECONDARYHLAHAFAD

Electrophysiology Mapping & Ablation Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

SECONDARYHLAHACAB

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

SECONDARYHLAHAFAH

Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)

Keywords

• Transesophageal pacing
• Cardiac electrophysiology
• Cardiac stress testing
• Esophageal catheters
• Cardiac pacing devices

Headquarters

HQ city

Tampa

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Capital Equipment Sales: Sale of reusable capital equipment including Model 7A Stimulator, Model 3 Preamplifier, and TAPSYSTEM™ Model 2A. These devices are the core platforms for transesophageal pacing and monitoring.
2. Disposable Catheters: Recurring revenue from sale of disposable esophageal catheters including TAPCATH 205, TAPCATH Model 1600, TAPSCOPE 210, and TAPSCOPE 550 series. Products are latex-free, single patient use.
3. Accessories and Cables: Sale of supporting accessories including instrument cables, patient lead wires, EP connect cables, interface cables, patient cables, and pole mounts.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

CardioCommand designs, develops, and manufactures FDA-cleared medical devices that perform transesophageal atrial pacing (TAP) and cardiac monitoring. Its product line combines reusable capital equipment (the Model 7A Stimulator, Model 3 Preamplifier, and TAPSYSTEM Model 2A Pulse Generator) with single-patient-use disposable esophageal catheters (TAPCATH and TAPSCOPE families) and supporting accessories, sold to hospital cardiology, electrophysiology, anesthesiology, and pediatric cardiology departments for cardiac stress testing, arrhythmia diagnosis, and perioperative pacing.

Product overview

CardioCommand is a medical device company offering two product lines: TAPSTRESS and TAPSYSTEM™. TAPSTRESS is used for cardiac stress testing with non-exercise stress testing and EP testing applications, while TAPSYSTEM™ is designed for anesthesiology and surgery settings. The product portfolio centers on transesophageal atrial pacing (TAP) technology, which leverages the anatomical proximity between the esophagus and the heart's left atrium for minimally invasive cardiac pacing and monitoring. Core equipment includes the Model 7A Stimulator, Model 3 Preamplifier, and TAPSYSTEM™ Model 2A, which connect to various disposable esophageal catheters (TAPCATH and TAPSCOPE product lines) for pacing and ECG recording. The catheters range from 5-18 French sizes and include specialized variants for different clinical applications, with accessories such as EP connect cables, patient lead wires, and interface cables completing the ecosystem.

Differentiator

Problem solved

Functional benefit

Brands

• TAPSTRESS: Cardiac stress testing system providing features for accelerating the heart for nonexercise stress testing, with applications in electrophysiology (EP) testing for diagnostic recording and therapeutic cardioversion.
• TAPSYSTEM
• TAP Technology
• TAPCATH
• TAPSCOPE

Products and services

• Model 7A Stimulator Transesophageal cardiac stimulator intended for temporary pacing of the atrium, designed for use with the Model 3 Preamplifier for recording of esophageal cardiac signals. Features constant current amplitude 0-40 mA, pacing rate 60-600 BPM, and pulse width 0-10 ms. Sold to hospital cardiology and electrophysiology departments.
• Model 3 Preamplifier Amplification and signal processing module designed to interface with CardioCommand esophageal catheters to enable recording of esophageal cardiac signals. Features differential input gain of 2 and a 20 Hz high-pass filter. Sold to hospital cardiology and electrophysiology departments.
• TAPSYSTEM Model 2A Esophageal pulse generator designed for heart rate control using transesophageal atrial pacing during surgery and postoperatively. Output current 5.5 to 40 mA; rate range 50-200 BPM. Sold to hospital anesthesiology and surgery departments for intraoperative and postoperative cardiac pacing and esophageal ECG monitoring.
• TAPCATH 205 5 French esophageal bipolar pacing and recording catheter, 100 cm length with stainless steel bipolar electrodes and 15.5 mm center-to-center interelectrode spacing. Sold in boxes of 5; latex-free, single patient use. Used for transesophageal pacing and recording in adult and pediatric electrophysiology procedures.
• TAPCATH Model 1600 6 French esophageal octapolar recording catheter, 102.9 cm length with stainless steel octapolar electrode configuration and 7.0 mm center-to-center interelectrode spacing. Sold in boxes of 5; latex-free, single patient use. Used for esophageal recording in electrophysiology procedures.
• TAPSCOPE 210 10 French esophageal bipolar pacing and recording catheter, 97.5 cm length with 10.2 mm electrodes and 30.6 mm center-to-center interelectrode spacing. Sold in boxes of 10; latex-free, single patient use. Used for esophageal pacing and recording in adult electrophysiology.
• TAPSCOPE 210-S with Stylet 10 French esophageal bipolar pacing and recording catheter with stylet for enhanced positioning control. Sold in boxes of 10; latex-free, single patient use. Used where additional catheter positioning control is required.
• TAPSCOPE 550 with Male Temperature Connector 18 French esophageal stethoscope with bipolar pacing and recording electrodes and YSI 400-compatible thermistor for esophageal temperature monitoring. 53.5 cm length, 10 mm electrodes, 4 cm center-to-center interelectrode spacing. Available in 25/box and 10/box pack sizes; latex-free, single patient use. Used during ablation procedures for thermal protection and pacing.
• TAPSCOPE 550F with Female Temperature Connector 18 French esophageal stethoscope with bipolar pacing and recording electrodes and YSI 400-compatible thermistor for esophageal temperature monitoring. Available with a female temperature connector in 25/box and 10/box pack sizes; latex-free, single patient use. Used during ablation procedures for thermal protection and pacing.
• EC-View ECG Adapter ECG adapter for the TAPSCOPE catheter family that provides an esophageal ECG output. Sold as an accessory to hospital cardiology and electrophysiology users of TAPSCOPE catheters.
• Instrument Cable for 7A Stimulator or Model 3 Preamp Replacement instrument cable for the Model 7A Stimulator or Model 3 Preamplifier. Sold as an accessory to clinical users of CardioCommand capital equipment.
• EP Connect Cable 10-foot EP connect cable with modular-to-pin connector for interfacing CardioCommand catheters with electrophysiology lab equipment. Sold as an accessory to EP lab users.
• EP Connect Cable Model 8032 (Octapolar) EP connect cable designed for octapolar CardioCommand catheters (such as the TAPCATH Model 1600). Sold as an accessory for electrophysiology procedures using octapolar catheters.
• Interface Cable for 7A/3 Replacement interface cable for the Model 7A Stimulator and Model 3 Preamplifier combination. Sold as an accessory to clinical users of CardioCommand capital equipment.
• Patient Cable (Model 2A) Patient cable for the TAPSYSTEM Model 2A pulse generator used in anesthesiology and surgery applications. Sold as an accessory for intraoperative and postoperative cardiac pacing.
• Pole Mount for TAPSYSTEM Model 2A Pole mount accessory for securing the TAPSYSTEM Model 2A esophageal pulse generator to an IV pole or equipment stand in operating room and perioperative settings.
• Patient Lead Wire (White, Right Arm) White patient lead wire designated for right-arm connection, used with CardioCommand equipment for ECG and pacing setups. Sold as an accessory for clinical users of CardioCommand capital equipment.
• Patient Lead Wire (Black, Left Arm) Black patient lead wire designated for left-arm connection, used with CardioCommand equipment for ECG and pacing setups. Sold as an accessory for clinical users of CardioCommand capital equipment.

Quantifiable outcome

• Non-exercise cardiac stress testing in half the time compared to dobutamine stress echo
• +6 more outcomes

Named customers12 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• BIOTRONIK: Cardiac rhythm management and EP company offering pacemakers, ICDs, and EP catheters. Comparable in targeting cardiology/EP hospital buyers with specialty pacing and monitoring products.
• Boston Scientific: Major player in cardiac rhythm management and electrophysiology, including ablation catheters and EP lab equipment. A direct competitor in EP labs and the most likely strategic acquirer of CardioCommand's catheter franchise.
• GE HealthCare: Provides cardiac stress testing systems, ECG monitoring, and patient monitoring infrastructure competing for hospital cardiology capital budgets alongside CardioCommand's TAP platform.
• MicroPort Scientific: Cardiac rhythm management business (formerly LivaNova CRM) competing in pacemakers and EP. Comparable as a mid-tier CRM/EP player with catheter products serving similar electrophysiology hospital workflows.
• Biosense Webster (Johnson & Johnson): World leader in electrophysiology ablation catheters and 3D mapping systems (CARTO). Operates the dominant integrated EP platform that competes with CardioCommand's standalone esophageal approach to arrhythmia management.
• Baxter (Hillrom Patient Monitoring): Hospital patient monitoring portfolio (acquired Hillrom) including cardiac monitoring sold into the same ICU, OR, and step-down units where CardioCommand's TAPSYSTEM is used for intraoperative pacing.
• Medtronic: Global leader in cardiac rhythm management, electrophysiology, and structural heart. Operates across the full pacing and EP ecosystem that CardioCommand serves in a niche, providing broad competitive context for any hospital CRM/EP buyer.
• Abbott: Cardiac rhythm management and EP portfolio spanning implantable CRM devices and ablation catheters. Competes for the same hospital EP lab budgets as CardioCommand and represents a potential acquirer for niche pacing assets.
• Philips (Cardiac Monitoring): Offers a broad portfolio of patient cardiac monitoring systems and stress testing equipment sold into the same hospital cardiology departments as CardioCommand's TAPSTRESS.

Emerging players

• iRhythm Technologies: Digital cardiac monitoring company (Zio patch) providing ambulatory ECG monitoring. Adjacent peer competing for hospital cardiac monitoring budgets and representing a modern digital alternative to CardioCommand's traditional catheter-based monitoring approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/cardiocommand

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CardioCommand